483
AMARIN PHARMACEUTICALS, INCFDA 483 - AMARIN PHARMACEUTICALS, INC - June 04, 2001
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Amarin Pharmaceuticals, Inc. in Warren, NJ on June 4, 2001, identified one observation. The firm was cited for an inadequate written procedure regarding the surveillance, receipt, evaluation, and reporting of adverse drug experiences. This indicates a deficiency in their pharmacovigilance processes.
- Person
Open in Dashboard
ID · cdb13607-5ea0-41ca-aa68-bbeac0d0f363